OncoSec Medical Inc (ONCSQ)

[twiz0019]

Remember also that Dr. Daud is heavily associated with both ONCS & Merck. ONCS through Dr. Daud & Dr. Pierce is SO "connected" with Merck, it isn't even funny. Dr. Pierce has been talking a lot about how ONCS is trying to address responders vs non-responders. Well, below is an article from April 8th about Merck's presentation at the recent AACR conference, talking about their MK-3475 drug and responders vs non-responders....a presentation done by Dr. Daud, no less! ONCS "motto" is "correcting the dots". Well in this case,how about CONNECTING the dots between ONCS & Merck!

I tried to post the link, but it didn't work....

Just google "Identifying Patients Who Respond to Immunomodulator MK-3475"